Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06765291 · ClinicalTrials.gov registry record · NA
Behavioral Intervention for Youth to Promote Vaping Cessation
A NA study of Nicotine Dependence and Vaping, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06765291: Recruiting NA study of Nicotine Dependence and Vaping, sponsored by Massachusetts General Hospital.
NCT06765291 is a NA study of Nicotine Dependence and Vaping that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 400 participants, above the 181-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (121% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06765291, a NA study of Nicotine Dependence and Vaping, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting support). Approximately 400 adolescents will be randomly assigned to one of two arms (1) QuitVaping intervention plus texting support to quit vaping and (2) EUC only.
Primary Outcome
The percent of participants who self-report nicotine vaping abstinence since the last visit on the timeline followback interview and have cotinine \<10ng/mL, assessed at study weeks 9-12. The primary comparison of interest is between the QV + EUC arms.
Conditions Studied
Interventions
- BEHAVIORAL QuitVaping
- BEHAVIORAL This is Quitting (TIQ)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Suite 320, Boston, MA 02114 - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-06-18 |
| Est. Completion | 2028-09-27 |
| Phase | NA |
What NCT06765291 shows while recruiting
NCT06765291 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 181-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (121% higher).
The record links to 3 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which QuitVaping is the first listed.
NCT06765291 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06765291 about?
NCT06765291 is a clinical study titled "Behavioral Intervention for Youth to Promote Vaping Cessation". This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting suppo...
What is the current status of trial NCT06765291?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-06-18. Estimated completion is 2028-09-27.
What conditions does trial NCT06765291 study?
This clinical trial studies the following conditions: Nicotine Dependence, Vaping, Vaping Teens.
What interventions are being tested in trial NCT06765291?
The interventions under investigation include: QuitVaping (BEHAVIORAL), This is Quitting (TIQ) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06765291?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06765291 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06765291's enrollment target sits among peer trials
400 8th of 67 higher than 60 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
NeuroControl of Nicotine Dependence
RECRUITING · NA
-
Abuse Liability and Appeal of Oral Nicotine Products
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI